- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01956383
Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses
Phase III of Study of Safety and Efficacy of the PrePex Device for MC Programs in Zimbabwe (Nurses Study)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Models show that to have the highest impact on the HIV epidemic, circumcision of up to 80% of men in high prevalence countries, where MC rates are low, needs to be achieved (UNAIDS 2009; Manicaland HIV/STD Prevention Project, 2008; Bollinger, et al, 2009). Hallett and colleagues in 2008 showed that for Zimbabwe specifically, HIV incidence could be reduced between 25% to 35% if about 50% of men are circumcised. All modelings conducted show that MC programs must be part of a comprehensive HIV prevention package as MC alone will not tip the HIV epidemic into a terminal decline.
The PrePex Device offers hope for rapid scale up of adult male circumcision in resource limited settings.
Once the safety and efficacy have been established, it is important to conduct operations research to determine how best to implement both device and surgical circumcisions in the national program. Thus, the Zimbabwe MOHCW is planning a three phase trial in order to determine the safety of the PrePexTM device, its performance and the ease of use in an implementation roll out.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Harare, Zimbabwe
- Znfpc Spilhaus Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages 18 - 30 years
- Uncircumcised
- Wants to be circumcised
- Agrees to be circumcised by any of the study methods ,PrePex or Surgical as appropriate
- HIV sero-negative
- Able to understand the study procedures and requirements
- Agrees to abstain from sexual intercourse and to keep caution not to directly rub the cut area if masturbating, for 8 weeks post removal (9 weeks total)
- Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision for a period of 8 weeks post removal (9 weeks total)
- Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
- Subject agrees to anonymous video and photographs of the procedure and follow up visits
- Agrees to stay overnight at the Hospital in order to follow pain measurements in the first 16 hours
Exclusion Criteria:
- Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
- HIV sero-positive
- Subject with the following diseases/conditions: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, epispadias
- Known bleeding / coagulation abnormality
- Uncontrolled diabetes
- Subject that to the opinion of the investigator is not a good candidate
- Subject does not agree to anonymous video and photographs of the procedure and follow up visits
- Refusal to take HIV test.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PrePex™ device
Adult male circumcision by the PrePex™ device
|
PrePex™ device for adult male circumcision.
The PrePex™ device facilitates adult male circumcision that is bloodless with no anesthesia and no sutures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To assess the safety of the PrePex device when circumcision is performed by nurses
Time Frame: 9 weeks
|
To assess the safety of the PrePex device by means of the following parameters: Clinical significant adverse event rate when circumcision is performed by nurses
|
9 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate the training needs of PrePexTM deployment using nurses
Time Frame: 9 weeks
|
|
9 weeks
|
Observation of in-field usability of device
Time Frame: 9 weeks
|
Observation of in-field usability of device using questionnaires
|
9 weeks
|
Obtain user feedback from nurses
Time Frame: 9 weeks
|
Obtain user feedback from nurses by questionnaires
|
9 weeks
|
Assess safety compared to physician deployment
Time Frame: 9 weeks
|
1. To assess the safety of the PrePex device by means of the following parameters: Clinical significant adverse event rate, when circumcision is performed by nurses comparing to Physicians.
|
9 weeks
|
Assess practicality and acceptability among nurses and patients
Time Frame: 9 weeks
|
Assess practicality and acceptability among nurses and patients using questionnaires.
|
9 weeks
|
Assess satisfaction of procedure among nurses and patients
Time Frame: 9 weeks
|
Assess satisfaction of procedure among nurses and patients using questionnaires.
|
9 weeks
|
Determine cost-effectiveness compared to surgical procedure
Time Frame: 9 weeks
|
1. Evaluating the cost-effectiveness when taking into account the following parameters: i. PrePex Procedure time and the resulting cost of provider's time compared to surgical procedure ii.
Cost of device compared to surgical procedure iii.
Cost of device training compared to surgical procedure training iv.
Cost of staff time for follow-up visits compared to compared to surgical procedure staff time v. Cost of equipment and supplies needed for the circumcision procedure for both PrePex and surgical circumcision.
|
9 weeks
|
Collaborators and Investigators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MRCZ/A/1628 Nurses Study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Circumcision Adult
-
University of North Carolina, Chapel HillBill and Melinda Gates Foundation; FHI 360; Impact Research & Development OrganizationCompletedVoluntary Medical Male Circumcision | Circumcision AdultKenya
-
ProgressusUnknownCircumcision, Male | Circumcision Status: Circumcised, Uncircumcised
-
Damanhour Teaching HospitalCompleted
-
Assiut UniversityUnknown
-
University of MichiganCompletedCircumcisionUnited States
-
Weill Medical College of Cornell UniversityBill and Melinda Gates FoundationCompleted
-
King Saud UniversityUnknownCircumcision, MaleSaudi Arabia
-
Simunye Primary Health CareCompleted
Clinical Trials on PrePex™ device
-
Ministry of Health and Child Welfare, ZimbabweCompleted
-
Ministry of Health, RwandaCompleted
-
Ministry of Health, RwandaCompletedHIV Prevention | Male Circumcision | Screen Failure Subjects | Narrow ForeskinRwanda
-
Ministry of Health, RwandaCompletedHIV Prevention | Male CircumcisionRwanda
-
Ministry of Health and Child Welfare, ZimbabweCompletedHIV Infections | Circumcision Adult | HIV CDC Category B2Zimbabwe
-
Ministry of Health, RwandaCompleted
-
University of WashingtonCenters for Disease Control and Prevention; University of Zimbabwe; Ministry... and other collaboratorsCompleted
-
FHI 360University of Illinois at Chicago; Bill and Melinda Gates Foundation; Nyanza... and other collaboratorsCompleted
-
Ministry of Health, RwandaMinistry of Defence, RwandaCompletedHIV Infections | HIV Prevention | Male CircumcisionRwanda
-
Ministry of Health, RwandaUnknownCircumcision, AdolescentsRwanda